By Tom Murphy and Haleluya Hadero

Amazon will soon make prescription drugs fall from the sky when the e-commerce giant becomes the latest company to test drone deliveries for medications.

The company said Wednesday that customers in College Station, Texas, can now get prescriptions delivered by a drone within an hour of placing their order.

The drone, programmed to fly from a delivery center with a secure pharmacy, will travel to the customer’s address, descend to a height of about four meters — or 13 feet — and drop a padded package.

Amazon says customers will be able to choose from more than 500 medications, a list that includes common treatments for conditions like the flu or pneumonia, but not controlled substances.

The company's Prime Air division began testing drone deliveries of common household items last December in College Station and Lockeford, California. Amazon spokesperson Jessica Bardoulas said the company has made thousands of deliveries since launching the service and is expanding it to include prescriptions based in part on customer requests.

Amazon Prime already delivers some medications from the company’s pharmacy inside of two days. But pharmacy Vice President John Love said that doesn’t help someone with an acute illness like the flu.

“What we’re trying to do is figure out how can we bend the curve on speed,” he said.

Amazon Pharmacy Chief Medical Officer Dr. Vin Gupta says the U.S. health care system generally struggles with diagnosing and treating patients quickly for acute illnesses, something that was apparent throughout the COVID-19 pandemic.

Narrowing the window between diagnosis and treatment makes many treatments more effective, he said.

Amazon is not the first company to explore prescription deliveries by drone. The drugstore chain CVS Health worked with UPS to test deliveries in 2019 in North Carolina but that program has ended, a CVS spokesman said.

Intermountain Health started providing drone deliveries of prescriptions in 2021 in the Salt Lake City area and has been expanding the program, according to Daniel Duersch, supply chain director for the health care system. Intermountain is partnering with the logistics company Zipline to use drones that drop packages by parachute.

Companies seeking to use drones for commercial purposes have faced hurdles from regulators who want to make sure things are operating safely. Amazon founder Jeff Bezos had predicted a decade ago that drones would be making deliveries by 2018. Even now, the e-commerce giant is only using the technology in two markets.

Lisa Ellman, the executive director of the Commercial Drone Alliance, an industry group that counts Amazon as one of its members, said to date, regulatory approvals have been limited to specific geographic areas and “in terms of their scope and usefulness to companies.”

That said, she noted regulators have also been issuing more approvals. Last month, the FAA gave the OK for Zipline and UPS to fly longer-range drones.

Walmart has also been working to expand its own drone deliveries.

Amazon says its drones will fly as high as 120 meters, or nearly 400 feet, before slowly descending when they reach the customer’s home. The drone will check to make sure the delivery zone is clear of pets, children or any other obstructions before dropping the package on a delivery marker.

The company said it hopes to expand the program to other markets, but it has no time frame for that.

Amazon has been growing its presence in health care for a few years now.

Aside from adding a pharmacy, it also spent nearly $4 billion to buy primary care provider One Medical. In August, the company added video telemedicine visits in all 50 states.

Share:
More In Business
17 Digital Asset Firms Launch CMIC, Committing to Safer Markets and Working with Regulators
Soildus Labs, a market compliance and surveillance technology provider for crypto firms, has spearheaded the launch of the Crypto Market Integrity Coalition, a pledge committing to a safe and sensibly-regulated crypto industry. Kathy Kraninger, VP of Regulatory Affairs at Solidus Labs, discusses on Cheddar News' Closing Bell the biggest problems in the digital asset space that this new initiative plans to solve.
Stocks Close Mixed as Investors Process Earnings, Look Ahead to Thursday CPI
Stocks closed mixed Monday as a broader tech sell-off continued, leading the Nasdaq to close down 0.58%. Investors are keeping an eye on earnings, and also looking ahead to Thursday's CPI data, which will give an idea of how hot inflation could still be running. Steve Sosnick, Chief Strategist at Interactive Brokers, joins Closing Bell to discuss today's close, the Federal Reserve's plans to raise interest rates and taper asset purchasing, his 2022 market outlook, and more.
Chip Shortage Continues to Impact Automobile Production
The global chip shortage continues to weigh on the automotive industry. For example, Ford says it is suspending or cutting production at eight of its factories in North America through next week due to the shortage. Balu Balakrishnan, President and CEO of Power Integrations, joins Cheddar News' Closing Bell, where he elaborates on why the chip shortage has dragged into 2022.
Dan Ives: Apple is Likely 'Aggressively' Pursuing Peloton Takeover
Peloton has weathered a seemingly never-ending storm the past few months: PR blunders, sinking customer demand, and in recent weeks, reported cost-cutting and potential layoffs. Now, several companies are said to be in the mix as potential buyers: Amazon, Netflix, Disney, and Apple. How likely is it that one of these companies pursues a deal — and how likely is it that it will be Apple who buys Peloton? Dan Ives, Managing Director of Equity Research at Wedbush Securities, joins Closing Bell to discuss his thoughts about Apple pursuing a Peloton takeover,
Astra Scrubs NASA ELaNa 41 Space Launch, Sees Its Stock Fall
Astra aborted the launch for NASA ELaNa 41 Mission out of Cape Canaveral on Monday due to what was described as a minor issue, but the company's stock fell nearly 14 percent following the news. Jim Cantrell, CEO and co-founder of Phantom Space, which builds and launches spacecraft of its own, joined Cheddar to discuss the scrubbed mission. “The last thing you want is for this to go wrong, you're better to err on the side of safety expectations,” Cantrell explained, noting that the mission delay was a normal event.
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
Load More